Search

everythinglearnresearchcommunity

for

Search:↓

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Lower SHBG levels may increase the risk of PCOS.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Finasteride can cause sexual problems and depression in young men.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Moderately high prolactin levels do not cause hair loss in women.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

COVID-19 may harm male fertility and damage the reproductive system.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.